Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
NTLA | Intellia Therapeutics, Inc. | VP, Chief Accounting Officer | $536K | -$55K | -9.3% | Mar 1, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|